Pds biotech appoints stephan toutain as chief operating officer

Princeton, n.j., may 02, 2024 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced the appointment of stephan toutain, ms, mba, as chief operating officer (coo), effective as of may 1, 2024.
PDSB Ratings Summary
PDSB Quant Ranking